John A. Alberta, Jr., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Basic Helix-Loop-Helix Transcription Factors | 11 | 2016 | 1136 | 0.510 |
Why?
|
| Oligodendroglia | 7 | 2019 | 536 | 0.420 |
Why?
|
| Nerve Tissue Proteins | 11 | 2014 | 4406 | 0.280 |
Why?
|
| Neural Stem Cells | 4 | 2019 | 882 | 0.280 |
Why?
|
| Platelet-Derived Growth Factor | 6 | 2005 | 617 | 0.250 |
Why?
|
| Astrocytoma | 3 | 2019 | 775 | 0.230 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 4 | 2000 | 178 | 0.220 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2001 | 12 | 0.190 |
Why?
|
| Glioma | 6 | 2018 | 3418 | 0.190 |
Why?
|
| Phosphotyrosine | 4 | 1997 | 455 | 0.190 |
Why?
|
| Phosphorylation | 10 | 2017 | 8297 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2019 | 2053 | 0.150 |
Why?
|
| Stem Cells | 9 | 2007 | 3521 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 1999 | 604 | 0.140 |
Why?
|
| raf Kinases | 1 | 2017 | 118 | 0.140 |
Why?
|
| Hydrocarbons | 1 | 2016 | 105 | 0.130 |
Why?
|
| Brain Neoplasms | 7 | 2019 | 8981 | 0.120 |
Why?
|
| DNA Damage | 2 | 2018 | 2439 | 0.120 |
Why?
|
| Signal Transduction | 6 | 2016 | 23342 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2001 | 2860 | 0.120 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 278 | 0.120 |
Why?
|
| Immunoassay | 1 | 1997 | 746 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 718 | 0.110 |
Why?
|
| Neuroglia | 3 | 2005 | 944 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2018 | 772 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 3602 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2019 | 1594 | 0.100 |
Why?
|
| Gene Dosage | 1 | 2017 | 1218 | 0.100 |
Why?
|
| Neurons | 7 | 2007 | 9416 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 979 | 0.100 |
Why?
|
| Wallerian Degeneration | 2 | 2005 | 68 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 507 | 0.100 |
Why?
|
| DNA-Binding Proteins | 4 | 2014 | 9574 | 0.100 |
Why?
|
| Antibodies | 2 | 2012 | 2420 | 0.100 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1018 | 0.090 |
Why?
|
| Embryo, Mammalian | 6 | 2014 | 1674 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2012 | 286 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 2858 | 0.090 |
Why?
|
| Cells, Cultured | 11 | 2014 | 18940 | 0.090 |
Why?
|
| Spinal Cord | 5 | 2006 | 1814 | 0.080 |
Why?
|
| Immunoblotting | 3 | 2011 | 1647 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2018 | 2472 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 1972 | 0.080 |
Why?
|
| Interneurons | 1 | 2014 | 591 | 0.080 |
Why?
|
| Antibody Specificity | 3 | 2001 | 1060 | 0.080 |
Why?
|
| Cell Differentiation | 7 | 2012 | 11471 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 1958 | 0.080 |
Why?
|
| Brain | 6 | 2014 | 26947 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3617 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2433 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 719 | 0.070 |
Why?
|
| Mice | 21 | 2019 | 81101 | 0.070 |
Why?
|
| Animals | 29 | 2019 | 167768 | 0.070 |
Why?
|
| Myeloid Cells | 1 | 2012 | 820 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2014 | 2907 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 11892 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 727 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2013 | 815 | 0.070 |
Why?
|
| Glioblastoma | 3 | 2016 | 3480 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2413 | 0.070 |
Why?
|
| Demyelinating Diseases | 2 | 2005 | 351 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2014 | 12094 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2017 | 5629 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2013 | 1090 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2006 | 801 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 2912 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2019 | 1245 | 0.060 |
Why?
|
| Peptides | 1 | 2016 | 4341 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2005 | 8143 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 482 | 0.060 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2003 | 34 | 0.060 |
Why?
|
| Carboplatin | 1 | 2007 | 788 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 460 | 0.060 |
Why?
|
| Myelin Sheath | 2 | 2005 | 652 | 0.060 |
Why?
|
| 3T3 Cells | 3 | 2000 | 1084 | 0.060 |
Why?
|
| Telencephalon | 1 | 2003 | 142 | 0.050 |
Why?
|
| Cell Proliferation | 4 | 2016 | 10416 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2018 | 3602 | 0.050 |
Why?
|
| Antigens | 2 | 2006 | 1445 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6127 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2005 | 1613 | 0.050 |
Why?
|
| Rats | 10 | 2005 | 23679 | 0.050 |
Why?
|
| Cerebral Cortex | 4 | 2005 | 5759 | 0.050 |
Why?
|
| Cell Division | 2 | 2007 | 4458 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 420 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 16886 | 0.040 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 96 | 0.040 |
Why?
|
| Receptor, erbB-2 | 3 | 2005 | 2553 | 0.040 |
Why?
|
| Hedgehog Proteins | 2 | 2001 | 769 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2001 | 305 | 0.040 |
Why?
|
| Pyrimidines | 3 | 2018 | 3006 | 0.040 |
Why?
|
| Genes, fos | 1 | 1999 | 173 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 3709 | 0.040 |
Why?
|
| Bromodeoxyuridine | 3 | 2007 | 311 | 0.040 |
Why?
|
| Cues | 2 | 2005 | 868 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1999 | 255 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 358 | 0.040 |
Why?
|
| Androstadienes | 1 | 1999 | 348 | 0.040 |
Why?
|
| Colorimetry | 1 | 1997 | 148 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 585 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 320 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2017 | 203 | 0.030 |
Why?
|
| Cell Lineage | 4 | 2011 | 2533 | 0.030 |
Why?
|
| Genes, Immediate-Early | 1 | 1997 | 101 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2017 | 122 | 0.030 |
Why?
|
| Genome | 1 | 2004 | 1739 | 0.030 |
Why?
|
| Receptors, Growth Factor | 1 | 1997 | 326 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 857 | 0.030 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2018 | 345 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 1 | 1997 | 280 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1141 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1249 | 0.030 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 200 | 0.030 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1996 | 198 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2017 | 408 | 0.030 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 9518 | 0.030 |
Why?
|
| Morpholines | 1 | 2018 | 580 | 0.030 |
Why?
|
| Dimerization | 1 | 2016 | 888 | 0.030 |
Why?
|
| Rabbits | 1 | 2001 | 4772 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1996 | 306 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 1128 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 542 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 2013 | 13591 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 1997 | 613 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2011 | 2626 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 655 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2014 | 239 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13447 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1477 | 0.030 |
Why?
|
| Gene Expression | 3 | 2005 | 7583 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2012 | 4257 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 9404 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 6371 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 929 | 0.020 |
Why?
|
| Transfection | 1 | 1999 | 5779 | 0.020 |
Why?
|
| Heme | 1 | 2013 | 313 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 795 | 0.020 |
Why?
|
| Permeability | 1 | 2013 | 718 | 0.020 |
Why?
|
| Protein Binding | 3 | 2012 | 9311 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 724 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 931 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 933 | 0.020 |
Why?
|
| Schwann Cells | 2 | 2005 | 196 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2011 | 5031 | 0.020 |
Why?
|
| Central Nervous System | 2 | 2011 | 1333 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 256 | 0.020 |
Why?
|
| Microglia | 1 | 2019 | 1349 | 0.020 |
Why?
|
| PC12 Cells | 2 | 2003 | 317 | 0.020 |
Why?
|
| K562 Cells | 1 | 2012 | 639 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1900 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 372 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3801 | 0.020 |
Why?
|
| Humans | 19 | 2019 | 758406 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 4 | 2014 | 22003 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2001 | 11070 | 0.020 |
Why?
|
| Piperazines | 1 | 2000 | 2511 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6520 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1835 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6234 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2004 | 2672 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18119 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3574 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2038 | 0.020 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 2 | 1999 | 36 | 0.020 |
Why?
|
| Meningioma | 1 | 1997 | 1217 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5864 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2014 | 943 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 22032 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2000 | 12759 | 0.020 |
Why?
|
| Proteins | 2 | 2000 | 6026 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1610 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2014 | 14354 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1360 | 0.020 |
Why?
|
| Immunologic Techniques | 2 | 1997 | 213 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 1816 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 2895 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7590 | 0.020 |
Why?
|
| Neuregulins | 1 | 2005 | 36 | 0.020 |
Why?
|
| Axotomy | 1 | 2005 | 71 | 0.020 |
Why?
|
| Ethidium | 1 | 2004 | 27 | 0.020 |
Why?
|
| Cuprizone | 1 | 2004 | 12 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 714 | 0.020 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2005 | 77 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 6068 | 0.020 |
Why?
|
| Lysophosphatidylcholines | 1 | 2004 | 77 | 0.020 |
Why?
|
| Sciatic Neuropathy | 1 | 2005 | 75 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2004 | 81 | 0.020 |
Why?
|
| Synapses | 1 | 2014 | 1757 | 0.010 |
Why?
|
| Ectoderm | 1 | 2004 | 137 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 4485 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 698 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4567 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2005 | 343 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 2638 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1745 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2004 | 332 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2012 | 2047 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 877 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 158 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 2004 | 279 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2005 | 523 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 640 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1543 | 0.010 |
Why?
|
| Gene Library | 1 | 2005 | 1059 | 0.010 |
Why?
|
| Age Factors | 2 | 2014 | 18358 | 0.010 |
Why?
|
| Male | 7 | 2017 | 358747 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2057 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2005 | 1339 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5781 | 0.010 |
Why?
|
| Neocortex | 1 | 2004 | 416 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 2470 | 0.010 |
Why?
|
| Apoptosis | 2 | 2011 | 9468 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 2816 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
| Testis | 1 | 2003 | 794 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1999 | 138 | 0.010 |
Why?
|
| Ligands | 1 | 2007 | 3258 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 692 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 1514 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2000 | 6209 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5779 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2004 | 998 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2176 | 0.010 |
Why?
|
| Child | 2 | 2018 | 79818 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 378 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4169 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 2000 | 526 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 1752 | 0.010 |
Why?
|
| Pyrroles | 1 | 2005 | 1130 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2004 | 1233 | 0.010 |
Why?
|
| Thalamus | 1 | 2004 | 1040 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 2697 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 2296 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 1132 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2005 | 2205 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 202 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 1996 | 46 | 0.010 |
Why?
|
| Vanadates | 1 | 1996 | 82 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1997 | 184 | 0.010 |
Why?
|
| Female | 5 | 2014 | 390323 | 0.010 |
Why?
|
| Receptor, trkC | 1 | 1996 | 63 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2000 | 2013 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3774 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 489 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2000 | 959 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2753 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 1996 | 159 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 17617 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20055 | 0.010 |
Why?
|
| Benzamides | 1 | 2000 | 1368 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 330 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2000 | 3096 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 562 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 29742 | 0.010 |
Why?
|
| Astrocytes | 1 | 1999 | 1337 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1997 | 3593 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 2416 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 4382 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2004 | 3204 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 29915 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 7980 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12951 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4902 | 0.000 |
Why?
|
| Kidney | 1 | 2003 | 7016 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 10748 | 0.000 |
Why?
|
| Liver | 1 | 2003 | 7502 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15225 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1999 | 3664 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1997 | 4087 | 0.000 |
Why?
|
| RNA | 1 | 1997 | 2716 | 0.000 |
Why?
|
| Lung | 1 | 2003 | 9985 | 0.000 |
Why?
|
| Cell Line | 1 | 1997 | 15591 | 0.000 |
Why?
|
| Time Factors | 1 | 2005 | 39872 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 9160 | 0.000 |
Why?
|